@article{kolnagou_efficacy_2011,
	title = {Efficacy, compliance and toxicity factors are affecting the rate of normalization of body iron stores in thalassemia patients using the deferiprone and  deferoxamine combination therapy.},
	volume = {35},
	issn = {1532-432X 0363-0269},
	doi = {10.3109/03630269.2011.576153},
	language = {eng},
	number = {3},
	journal = {Hemoglobin},
	author = {Kolnagou, Annita and Kleanthous, Marios and Kontoghiorghes, George J.},
	year = {2011},
	pmid = {21599431},
	note = {Place: England},
	keywords = {Deferiprone, Deferoxamine/*therapeutic use, Drug Therapy, Combination, Ferritins/blood/drug effects, Humans, Iron Chelating Agents/pharmacokinetics/therapeutic use/toxicity, Iron/*metabolism, Liver/metabolism, Longitudinal Studies, Magnetic Resonance Imaging, Myocardium/metabolism, Pyridones/*therapeutic use, beta-Thalassemia/*drug therapy/metabolism},
	pages = {186--198},
}

{"_id":"4cSuJqnBXeaC6QPzX","bibbaseid":"kolnagou-kleanthous-kontoghiorghes-efficacycomplianceandtoxicityfactorsareaffectingtherateofnormalizationofbodyironstoresinthalassemiapatientsusingthedeferiproneanddeferoxaminecombinationtherapy-2011","author_short":["Kolnagou, A.","Kleanthous, M.","Kontoghiorghes, G. J."],"bibdata":{"bibtype":"article","type":"article","title":"Efficacy, compliance and toxicity factors are affecting the rate of normalization of body iron stores in thalassemia patients using the deferiprone and deferoxamine combination therapy.","volume":"35","issn":"1532-432X 0363-0269","doi":"10.3109/03630269.2011.576153","language":"eng","number":"3","journal":"Hemoglobin","author":[{"propositions":[],"lastnames":["Kolnagou"],"firstnames":["Annita"],"suffixes":[]},{"propositions":[],"lastnames":["Kleanthous"],"firstnames":["Marios"],"suffixes":[]},{"propositions":[],"lastnames":["Kontoghiorghes"],"firstnames":["George","J."],"suffixes":[]}],"year":"2011","pmid":"21599431","note":"Place: England","keywords":"Deferiprone, Deferoxamine/*therapeutic use, Drug Therapy, Combination, Ferritins/blood/drug effects, Humans, Iron Chelating Agents/pharmacokinetics/therapeutic use/toxicity, Iron/*metabolism, Liver/metabolism, Longitudinal Studies, Magnetic Resonance Imaging, Myocardium/metabolism, Pyridones/*therapeutic use, beta-Thalassemia/*drug therapy/metabolism","pages":"186–198","bibtex":"@article{kolnagou_efficacy_2011,\n\ttitle = {Efficacy, compliance and toxicity factors are affecting the rate of normalization of body iron stores in thalassemia patients using the deferiprone and deferoxamine combination therapy.},\n\tvolume = {35},\n\tissn = {1532-432X 0363-0269},\n\tdoi = {10.3109/03630269.2011.576153},\n\tlanguage = {eng},\n\tnumber = {3},\n\tjournal = {Hemoglobin},\n\tauthor = {Kolnagou, Annita and Kleanthous, Marios and Kontoghiorghes, George J.},\n\tyear = {2011},\n\tpmid = {21599431},\n\tnote = {Place: England},\n\tkeywords = {Deferiprone, Deferoxamine/*therapeutic use, Drug Therapy, Combination, Ferritins/blood/drug effects, Humans, Iron Chelating Agents/pharmacokinetics/therapeutic use/toxicity, Iron/*metabolism, Liver/metabolism, Longitudinal Studies, Magnetic Resonance Imaging, Myocardium/metabolism, Pyridones/*therapeutic use, beta-Thalassemia/*drug therapy/metabolism},\n\tpages = {186--198},\n}\n\n","author_short":["Kolnagou, A.","Kleanthous, M.","Kontoghiorghes, G. J."],"key":"kolnagou_efficacy_2011","id":"kolnagou_efficacy_2011","bibbaseid":"kolnagou-kleanthous-kontoghiorghes-efficacycomplianceandtoxicityfactorsareaffectingtherateofnormalizationofbodyironstoresinthalassemiapatientsusingthedeferiproneanddeferoxaminecombinationtherapy-2011","role":"author","urls":{},"keyword":["Deferiprone","Deferoxamine/*therapeutic use","Drug Therapy","Combination","Ferritins/blood/drug effects","Humans","Iron Chelating Agents/pharmacokinetics/therapeutic use/toxicity","Iron/*metabolism","Liver/metabolism","Longitudinal Studies","Magnetic Resonance Imaging","Myocardium/metabolism","Pyridones/*therapeutic use","beta-Thalassemia/*drug therapy/metabolism"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/4516419/collections/XQQRG67P/items?key=iUGtZ5FwZ23zKgsOTKK1Vgda&format=bibtex&limit=100","dataSources":["MnayAXw3qciX87bz7"],"keywords":["deferiprone","deferoxamine/*therapeutic use","drug therapy","combination","ferritins/blood/drug effects","humans","iron chelating agents/pharmacokinetics/therapeutic use/toxicity","iron/*metabolism","liver/metabolism","longitudinal studies","magnetic resonance imaging","myocardium/metabolism","pyridones/*therapeutic use","beta-thalassemia/*drug therapy/metabolism"],"search_terms":["efficacy","compliance","toxicity","factors","affecting","rate","normalization","body","iron","stores","thalassemia","patients","using","deferiprone","deferoxamine","combination","therapy","kolnagou","kleanthous","kontoghiorghes"],"title":"Efficacy, compliance and toxicity factors are affecting the rate of normalization of body iron stores in thalassemia patients using the deferiprone and deferoxamine combination therapy.","year":2011}